Definitive Healthcare Corp. (NASDAQ:DH) Receives Average Rating of "Reduce" from Brokerages

Key Points

• Definitive Healthcare received an average “Reduce” rating from 10 brokerages: three sell ratings, six holds and one strong buy. The average 12-month price target is $1.47.
• Shares opened at $1.02 and remain well below their 52-week high of $4.35. Morgan Stanley recently cut its price target to $1.50, while Deutsche Bank maintained a $1.00 target.
• The company modestly beat quarterly EPS expectations at $0.05 versus $0.04, but revenue of $55.2 million fell slightly short of estimates and net margin remained deeply negative at 72.28%.

Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) has been given an average rating of "Reduce" by the ten brokerages that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $1.4714.

A number of analysts have issued reports on the company. Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a research report on Sunday. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Definitive Healthcare in a research report on Monday, August 31st. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $1.00 price target on shares of Definitive Healthcare in a research note on Wednesday, August 12th. Morgan Stanley decreased their price objective on Definitive Healthcare from $2.50 to $1.50 and set an "equal weight" rating for the company in a report on Tuesday, August 11th. Finally, BTIG Research restated a "neutral" rating on shares of Definitive Healthcare in a research note on Friday, September 4th.

Definitive Healthcare Stock Performance

Shares of DH stock opened at $1.02 on Tuesday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.86 and a current ratio of 1.86. The firm has a market cap of $108.89 million, a price-to-earnings ratio of -0.64, a P/E/G ratio of 12.96 and a beta of 1.40. Definitive Healthcare has a 52 week low of $0.61 and a 52 week high of $4.35. The firm's 50-day simple moving average is $0.79 and its two-hundred day simple moving average is $0.91.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last released its earnings results on Monday, August 10th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.01. The firm had revenue of $55.20 million during the quarter, compared to the consensus estimate of $55.47 million. Definitive Healthcare had a negative net margin of 72.28% and a positive return on equity of 3.55%. Definitive Healthcare has set its FY 2026 guidance at 0.180-0.200 EPS and its Q3 2026 guidance at 0.040-0.050 EPS. As a group, equities analysts forecast that Definitive Healthcare will post 0.06 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Squarepoint Ops LLC lifted its position in shares of Definitive Healthcare by 46.5% during the second quarter. Squarepoint Ops LLC now owns 351,575 shares of the company's stock worth $292,000 after acquiring an additional 111,634 shares in the last quarter. Corient Private Wealth LP purchased a new stake in Definitive Healthcare during the 2nd quarter worth about $378,000. Williams & Novak LLC lifted its holdings in Definitive Healthcare by 155.8% during the 2nd quarter. Williams & Novak LLC now owns 78,610 shares of the company's stock worth $65,000 after purchasing an additional 47,880 shares in the last quarter. Irenic Capital Management LP bought a new position in Definitive Healthcare in the 1st quarter worth about $71,000. Finally, Flywheel Private Wealth LLC bought a new position in Definitive Healthcare in the 1st quarter worth about $83,000. 98.67% of the stock is owned by institutional investors.

Definitive Healthcare Company Profile

Definitive Healthcare NASDAQ: DH is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company's flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.